F. Lambert et al., RELATIONS BETWEEN MYOCARDIAL-CONTRACTILITY, MYOSIN PHENOTYPE, AND PLASMA ANGIOTENSIN-CONVERTING ENZYME-ACTIVITY IN THE CARDIOMYOPATHIC HAMSTER, Journal of cardiovascular pharmacology, 25(3), 1995, pp. 410-415
Angiotensin-converting enzyme (ACE) inhibitors have been shown to pres
erve myocardial contractility in the cardiomyopathic Syrian hamster (C
SH). To determine if this was related to changes in myosin heavy-chain
(MHC) phenotype, myosin isoform patterns and mechanical properties we
re studied in the same left ventricular papillary muscle from CSH of t
he Bio 53.58-dilated strain. From age 1 to 6 months, 22 CSH randomly r
eceived either perindopril 1 mg/kg/day in distilled water (PE, n = 11)
or distilled water only (PL, n = 11), and seven control golden Syrian
hamsters (C) received distilled water by force-feeding. Compared to C
, PL had a lower V-max (p < 0.01), a lower amount of alpha-MHC (p < 0.
01), and an unchanged twitch duration. In PE, as compared to PL, there
was a higher V-max (p < 0.05), a higher alpha-MHC (p < 0.05), and an
unchanged twitch duration. There was a positive relationship between V
-max and alpha-MHC in the population taken as a whole (p < 0.01), and
when muscles from C and PL groups were plotted together (p < 0.001), b
ut neither within each group, nor when PL and PE were plotted together
. Our study indicates that in CSH (a) the preserved contractility with
ACE-inhibitor treatment is associated with limitation of isomyosin sh
ift induced by the myopathic process, but no cause-to-effect relations
hip could be demonstrated on the basis of our data, and (b) adaptive c
hanges in twitch duration were not observed either in untreated CSH or
in perindopril-treated CSH, despite significant changes in alpha-MHC
content.